en

PRODUCT DETAIL

REZZAYO 200 mg prášok na koncentrát na infúzny roztok

Code 5217E
MA number EU/1/23/1775/001
Product Form: plc ifc 1x200 mg (liek.inj.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU Orphan
Therapeutic Class: 26 - ANTIMYCOTICA (LOKÁLNE A CELKOVÉ)
ATC:
J ANTIINFECTIVES FOR SYSTEMIC USE
J02 ANTIMYCOTICS FOR SYSTEMIC USE
J02A ANTIMYCOTICS FOR SYSTEMIC USE
J02AX Other antimycotics for systemic use
J02AX08 Rezafungin acetate
Shelf life: 36
Container: glass vial
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 22.12.2023
Validity: 22.12.2028
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 03.01.2024
eu-flag.png sk-flag.png